These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

822 related articles for article (PubMed ID: 29953746)

  • 1. Low recurrence rate of head and neck basal cell carcinoma treated with Mohs micrographic surgery: A retrospective study of 1021 cases.
    Kuiper EM; van den Berge BA; Spoo JR; Kuiper J; Terra JB
    Clin Otolaryngol; 2018 Oct; 43(5):1321-1327. PubMed ID: 29953746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mohs micrographic surgery for basal cell carcinomas: results of a Spanish retrospective study and Kaplan–Meier survival analysis of tumour recurrence.
    Català A; Garces JR; Alegre M; Gich IJ; Puig L
    J Eur Acad Dermatol Venereol; 2014 Oct; 28(10):1363-9. PubMed ID: 25383396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mohs' micrographic surgery for treatment of basal cell carcinoma of the face--results of a retrospective study and review of the literature.
    Smeets NW; Kuijpers DI; Nelemans P; Ostertag JU; Verhaegh ME; Krekels GA; Neumann HA
    Br J Dermatol; 2004 Jul; 151(1):141-7. PubMed ID: 15270883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrence rates of periocular basal cell carcinoma following Mohs micrographic surgery: a retrospective study.
    Sin CW; Barua A; Cook A
    Int J Dermatol; 2016 Sep; 55(9):1044-7. PubMed ID: 27152747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgical excision versus Mohs' micrographic surgery for primary and recurrent basal-cell carcinoma of the face: a prospective randomised controlled trial with 5-years' follow-up.
    Mosterd K; Krekels GA; Nieman FH; Ostertag JU; Essers BA; Dirksen CD; Steijlen PM; Vermeulen A; Neumann H; Kelleners-Smeets NW
    Lancet Oncol; 2008 Dec; 9(12):1149-56. PubMed ID: 19010733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Basal cell carcinoma of the head region: therapeutical results of 350 lesions treated with Mohs micrographic surgery.
    Veronese F; Farinelli P; Zavattaro E; Zuccoli R; Bonvini D; Leigheb G; Colombo E
    J Eur Acad Dermatol Venereol; 2012 Jul; 26(7):838-43. PubMed ID: 21707774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Appropriate use criteria for basal cell carcinoma Mohs surgery at a single center in the face of high-burden skin cancer: a retrospective cohort study.
    Fantini BC; Bueno Filho R; Chahud F; Souza CDS
    J Dermatolog Treat; 2019 Feb; 30(1):74-80. PubMed ID: 29727201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of periocular basal cell carcinoma by Mohs micrographic surgery.
    Litwin AS; Rytina E; Ha T; René C; Woodruff SA
    J Dermatolog Treat; 2013 Jun; 24(3):232-4. PubMed ID: 22551161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrence of periocular basal cell carcinoma and squamous cell carcinoma after Mohs micrographic surgery: a retrospective cohort study.
    Weesie F; Naus NC; Vasilic D; Hollestein LM; van den Bos RR; Wakkee M
    Br J Dermatol; 2019 May; 180(5):1176-1182. PubMed ID: 30536656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Basosquamous carcinoma and metatypical basal cell carcinoma: a review of treatment with Mohs micrographic surgery.
    Allen KJ; Cappel MA; Killian JM; Brewer JD
    Int J Dermatol; 2014 Nov; 53(11):1395-403. PubMed ID: 24961583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical excision versus Mohs' micrographic surgery for basal cell carcinoma of the face: A randomised clinical trial with 10 year follow-up.
    van Loo E; Mosterd K; Krekels GA; Roozeboom MH; Ostertag JU; Dirksen CD; Steijlen PM; Neumann HA; Nelemans PJ; Kelleners-Smeets NW
    Eur J Cancer; 2014 Nov; 50(17):3011-20. PubMed ID: 25262378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. It's time for Mohs: Micrographic surgery for the treatment of high-risk basal cell carcinomas of the head and neck regions.
    Dika E; Veronesi G; Patrizi A; De Salvo S; Misciali C; Baraldi C; Mussi M; Fabbri E; Tartari F; Lambertini M
    Dermatol Ther; 2020 Jul; 33(4):e13474. PubMed ID: 32391961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue-sparing properties of Mohs micrographic surgery for infiltrative basal cell carcinoma.
    van Kester MS; Goeman JJ; Genders RE
    J Am Acad Dermatol; 2019 Jun; 80(6):1700-1703. PubMed ID: 30710602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retrospective audit of patients referred for further treatment following Mohs surgery for non-melanoma skin cancer.
    Wee E; Goh MS; Estall V; Tiong A; Webb A; Mitchell C; Murray W; Tran P; McCormack CJ; Henderson M; Hiscutt EL
    Australas J Dermatol; 2018 Nov; 59(4):302-308. PubMed ID: 29349770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Basal cell carcinoma treated with Mohs surgery in Australia II. Outcome at 5-year follow-up.
    Leibovitch I; Huilgol SC; Selva D; Richards S; Paver R
    J Am Acad Dermatol; 2005 Sep; 53(3):452-7. PubMed ID: 16112352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrent basal cell carcinoma after incomplete resection.
    Robinson JK; Fisher SG
    Arch Dermatol; 2000 Nov; 136(11):1318-24. PubMed ID: 11074691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors predictive of recurrence, metastasis, and death from primary basal cell carcinoma 2 cm or larger in diameter.
    Morgan FC; Ruiz ES; Karia PS; Besaw RJ; Neel VA; Schmults CD
    J Am Acad Dermatol; 2020 Sep; 83(3):832-838. PubMed ID: 31600531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of Mohs micrographic surgery for determination of residual tumor in incompletely excised basal cell carcinoma.
    Bieley HC; Kirsner RS; Reyes BA; Garland LD
    J Am Acad Dermatol; 1992 May; 26(5 Pt 1):754-6. PubMed ID: 1583176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical margin marking for high-risk basal cell carcinomas of the cephalic region: a single-centre experience.
    Cecchi R; Bartoli L; Brunetti L; Pavesi M; Rapicano V
    G Ital Dermatol Venereol; 2011 Apr; 146(2):79-84. PubMed ID: 21505392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High recurrence rates of Basal cell carcinoma after mohs surgery in patients with chronic lymphocytic leukemia.
    Mehrany K; Weenig RH; Pittelkow MR; Roenigk RK; Otley CC
    Arch Dermatol; 2004 Aug; 140(8):985-8. PubMed ID: 15313816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.